Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsDec 13 09:31 ET · Ratings

Sector Update: Health Care Stocks Steady Premarket Friday

MT NewswiresDec 13 09:17 ET

Express News | Needham Reiterates Buy on Geron, Maintains $6 Price Target

BenzingaDec 13 09:05 ET

Buy Rating on Geron Driven by EU Approval Prospects and Strategic Commercialization of Rytelo

TipRanksDec 13 09:05 ET · Ratings

Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation

MT NewswiresDec 13 07:30 ET

Geron Says Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Approval Of RYTELO (Imetelstat) For Treatment Of Adult Patients With Transfusion-dependent (TD) Anemia Due To Very Low, Low Or Intermediate Risk...

BenzingaDec 13 06:38 ET